Skip links
Companies
› Bermuda › Kiniksa Pharmaceuticals, Ltd.
Company registry profile

Kiniksa Pharmaceuticals, Ltd.

Active

From the registry

Registration details

Incorporation Date
Not disclosed
Company Type
Not disclosed
Address
Hamilton, Bermuda
Status
Active
Country
Bermuda
Source: Bermuda Monetary Authority / Registrar of CompaniesRegistry coverage
Registry summary

Company overview

Kiniksa Pharmaceuticals, Ltd. is a registered legal entity registered in Bermuda, and its current status with Bermuda Monetary Authority / Registrar of Companies is active. Its registered address on file is Hamilton, Bermuda. 5 shareholders are on record for Kiniksa Pharmaceuticals, Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Bermuda Monetary Authority / Registrar of Companies and was last updated on 22 September 2026.

Data Provenance
This record is sourced directly from official government registries, including Bermuda Monetary Authority / Registrar of Companies.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

5

Shareholders of Kiniksa Pharmaceuticals, Ltd.

Five shareholders are currently on record for Kiniksa Pharmaceuticals, Ltd., held on the register of members, filed under the Companies Act 1981. The largest of these is Blackrock Inc., holding 6% — the largest recorded stake — followed by Baker Brothers Advisors, LLC at 5.4%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Data availability

The register reports 39 shareholders in total, though only the top 5 by holding are shown in this view.

Swipe or scroll for more columns

Shareholder Type Holding Source Document
Blackrock Inc. 6% Bermuda Monetary Authority / Registrar of Companies
Baker Brothers Advisors, LLC 5.4% Bermuda Monetary Authority / Registrar of Companies
State Street Corporation 3.1% Bermuda Monetary Authority / Registrar of Companies

Officers

5

Directors and officers of Kiniksa Pharmaceuticals, Ltd.

The Ceo & Chairman Of The Board of Kiniksa Pharmaceuticals, Ltd. currently on record is SANJ PATEL; five officers are currently on record for Kiniksa Pharmaceuticals, Ltd., filed with Bermuda Monetary Authority / Registrar of Companies. Management authority at Kiniksa Pharmaceuticals, Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

Data availability

The register reports 10 officers in total, including past appointments, though only the 5 most relevant records are shown here.

SP
SANJ PATEL ACTIVE

Residence
🇧🇲 Bermuda
Occupation
Ceo & Chairman Of The Board

RF
Rachel Frank ACTIVE

Residence
🇧🇲 Bermuda
Occupation
Senior Director Of Investor Relations & Corporate Communications

ET
Eben Tessari ACTIVE

Residence
🇧🇲 Bermuda
Occupation
Senior Vp & Coo

CM
Chad Morin ACTIVE

Residence
🇧🇲 Bermuda
Occupation
Senior Vp & Chief Compliance Officer

MZ
Madelyn Zeylikman ACTIVE

Residence
🇧🇲 Bermuda
Occupation
Svp, General Counsel & Secretary

Registry questions

Frequently asked questions

Who owns Kiniksa Pharmaceuticals, Ltd.?

Five shareholders are currently on record for Kiniksa Pharmaceuticals, Ltd., held on the register of members, filed under the Companies Act 1981. The largest of these is Blackrock Inc., holding 6% — the largest recorded stake — followed by Baker Brothers Advisors, LLC at 5.4%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is Kiniksa Pharmaceuticals, Ltd.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for Kiniksa Pharmaceuticals, Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does Kiniksa Pharmaceuticals, Ltd. have on record?

5 shareholders are shown on record for Kiniksa Pharmaceuticals, Ltd.. The register reports 39 in total; only the top 5 by holding are shown here.

Is Kiniksa Pharmaceuticals, Ltd. still an active company?

Kiniksa Pharmaceuticals, Ltd.'s status on Bermuda Monetary Authority / Registrar of Companies is listed as active.

What is Kiniksa Pharmaceuticals, Ltd.'s registered address?

The registered address on file for Kiniksa Pharmaceuticals, Ltd. is Hamilton, Bermuda.

Who are the officers/directors of Kiniksa Pharmaceuticals, Ltd.?

The Ceo & Chairman Of The Board of Kiniksa Pharmaceuticals, Ltd. currently on record is SANJ PATEL; five officers are currently on record for Kiniksa Pharmaceuticals, Ltd., filed with Bermuda Monetary Authority / Registrar of Companies. Management authority at Kiniksa Pharmaceuticals, Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Other companies in Bermuda · Healthcare

All companies in Bermuda · Human Health and Social Work Activities in Bermuda

This website uses cookies to improve your web experience.